Aprogen Medicines Inc. (KRX: 007460)

Aprogen Medicines Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 15, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	271,415	234,315	399,707	335,573	374,121	417,454
Market Cap Growth	-3.50%	-41.38%	19.11%	-10.30%	-10.38%	-41.76%
Enterprise Value	656,127	577,535	792,820	588,371	548,883	565,375
Last Close Price	1020.00	960.00	1716.00	5055.00	6135.00	8175.00
PS Ratio	1.69	1.56	5.10	12.76	2.94	5.33
PB Ratio	2.34	0.56	0.87	-416.12	0.54	0.81
P/TBV Ratio	2.73	1.67	1.93	-	1.19	1.57
P/FCF Ratio	-	-	-	-	18.75	-
P/OCF Ratio	-	-	-	-	16.60	-
EV/Sales Ratio	4.35	3.84	10.12	22.38	4.32	7.23
EV/EBITDA Ratio	-	-	-	-	76.74	140.43
EV/EBIT Ratio	-	-	-	-	192.99	729.45
EV/FCF Ratio	-10.20	-	-	-	27.50	-
Debt / Equity Ratio	0.30	0.30	0.20	-560.94	0.12	0.16
Debt / EBITDA Ratio	-	-	-	-	11.98	21.10
Debt / FCF Ratio	-	-	-	-	4.29	-
Asset Turnover	0.25	0.25	0.15	0.04	0.17	0.15
Inventory Turnover	1.38	1.90	1.84	1.55	5.37	5.28
Quick Ratio	0.69	0.53	0.85	0.07	3.11	1.88
Current Ratio	1.28	1.15	2.35	0.24	5.11	3.03
Return on Equity (ROE)	-21.84%	-22.14%	-50.45%	-34.60%	-5.41%	5.14%
Return on Assets (ROA)	-9.20%	-9.94%	-13.57%	-9.13%	0.24%	0.09%
Return on Capital (ROIC)	-10.12%	-10.86%	-14.58%	-9.76%	0.26%	0.10%
Earnings Yield	-19.12%	-23.74%	-24.68%	-27.99%	-12.43%	-2.60%
FCF Yield	-23.69%	-35.71%	-33.30%	-35.50%	5.33%	-2.15%
Buyback Yield / Dilution	27.89%	-16.69%	-16.73%	-206.64%	-24.06%	-168.99%
Total Shareholder Return	27.89%	-16.69%	-16.73%	-206.64%	-24.06%	-168.99%

Source: S&P Capital IQ. Standard template. Financial Sources.